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Chromosomal analysis revealed a de novo “apparently” balanced
double rearrangement: a balanced translocation between
chromosomes 2 and 3 at breakpoints 2q22 and 3q13.2 and a
pericentric 8p23.1q24.1 inversion, both of which were confirmed by
FISH analysis. Subsequently, array-CGH analysis revealed a novel het-
erozygous deletion within the EXT1 gene at the inversion break-
points, rendering the inversion as unbalanced. The inheritance mode
as well as the size of the deletion was further investigated by qRT-
PCR and the deletion was characterized as a de novo 3.1kb deletion
removing exon 10. The inversion in combination with the 8p23.1 de-
letion most likely abolishes the transcription of EXT1 downstream of
exon 10 hence resulting in a truncated protein.
To conclude, a rare and novel pathogenic cause of HME is presented
in this study, highlighting the importance of additional
comprehensive cytogenetic investigation when EXT1 and EXT2
mutation analysis is negative.
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11p13 deletions are associated either with isolated congenital
aniridia (OMIM #106210) (AN) or with WAGR syndrome (OMIM
#194072) where aniridia is one of pathognomonic signs. If the
deletion encompasses the WT1 gene Wilms tumor develops (in
~70% cases). Early nephroblastoma development poses the urgency
of DNA diagnostics in all patients with clinical signs of congenital
aniridia.
Materials and methods.
DNA diagnostics was performed in 195 patients from 163 unrelated
families from Russia: 184 patients from 152 unrelated families with
AN and 11 patients from 11 families with WAGR. Screening for
mutations was carried out by Sanger sequencing, MLPA, and FISH
analysis if the WT1 gene was affected.
Results.
A total of 149 different mutations: 107 small PAX6 intragenic variants
and 42 large deletions were found in patients with AN. In all WAGR
patients deletions encompassing the PAX6 and WT1 genes were
defined. 3 patients showed neither small PAX6 mutations nor
microdeletions of 11p13.
The proportion of chromosome rearrangements was about one third
of all genetic causes of AN (42/149). The localization of chromosome
breakpoints and the length of the deleted regions varied
(0.1÷7.5Mb). The same deletion affecting PAX6 downstream
regulatory regions (0.5÷1.5Mb) occurred especially frequent (17/42).
One deletion (1/42) was found to be the result of pericentric
inversion of chromosome 11 inv(11)(p13q14).
Conclusion.
Analysis of chromosomal imbalance of the 11p13 region is an
important step of the DNA diagnostics in patients with AN in Russia,
not only due to the importance of early detection of WAGR
deletions, but also by the high frequency of large chromosome
rearrangements among genetic causes of AN in the Russian
population.
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Chromosomal microarray analysis (CMA) is the first-tier test for devel-
opmental delay, autism spectrum disorders, and congenital abnor-
malities in postnatal diagnosis and for ultrasound abnormalities in
prenatal diagnosis.
The detection of variants with clinical significance by CMA, when
compared to karyotype, can increase up to 10-20% in postnatal diag-
nosis and up to 5-18% in prenatal diagnosis. Nevertheless CMA also
detects incomplete penetrance neuro-Susceptibility Loci Copy Num-
ber Variants (SL-CNV), which although having clinical significance
have an uncertain prognosis.
The aim of this study is to identify from the literature a set of SL-
CNV, and the corresponding penetrance for each variant, determin-
ing their occurrence in our cohort of postnatal samples ran between
January 2012 and August 2018 and prenatal samples ran between
January 2015 and August 2018.
We have established a 21 SL-CNV set, and from a total of 835 postna-
tal samples and 317 prenatal samples we have identified 36 and 11
cases, respectively, with a variant in one of the 21 established SL-
CNV.
The percentage of cases with a SL-CNV is relatively similar be-
tween postnatal samples (4.5%) and prenatal samples (3.5%), al-
though the reason of referral for the two groups is not
completely overlapping and also the total number of prenatal
samples represents about half of the time span of the postnatal
samples, which might have underestimated their occurrence. The
estimated penetrance for each of the established SL-CNV present
some inter-publication variability, especially concerning samples
with different phenotypes. Nevertheless some variants show
concordance.
Estimating the penetrance for SL-CNV, and their clinical impact for
the patient or carriers in the family, is a complex task. Only time, ana-
lysis of larger cohorts, and future knowledge of genotype-
environment-phenotype interactions will overcome this difficulty, de-
creasing uncertainty for the around 4% of patients diagnosed by
CMA.
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Background
Interstitial 19q13.32 microdeletions are rare and have been reported
in only five patients so far. Common features mentioned in the
literature include intellectual disability/developmental delay, facial
asymmetry, ptosis, oculomotor paralysis, orofacial clefting,
micrognathia, kyphoscoliosis, cardiac abnormalities and constipation,.
Since only a few patients have been reported, little is known about
the phenotypic spectrum of these deletions.
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